affigene® HBV trender

The affigene® HBV trender assay allows correct monitoring of HBV DNA with high sensitivity and wide dynamic range in a standardized and CE-labelled format utilizing real-time PCR detection.

affigene® HBV trender is characterized by:

Fast results and ease-of-use

· ready-to-use reagents

· real-time PCR detection, fully licensed

· harmonised test profiles with other affigene® trender for multi-target runs

· Small sample volume (200 µl) serum/plasma (ACD/EDTA)

High performance

· high sensitivity

· wide dynamic range

· prevention of false negative results through a built-in internal control

· prevention of false positive results through selective UDG amplification, closed-tube reactions, and single-use reagents

Flexibility

• CE labelled flexible solution for sample preparation from different cell free sample matrices such as serum and plasma (ACD and EDTA)
• CE labelled for manual as well as automated sample preparation (validated in combination with the NucliSens easyMAG system)
• CE label valid on multiple real-time PCR platforms for flexible detection possibilities:
  - Mx3000P/3005P (Stratagene, La Jolla, USA)
  - iCycler iQ/iQ5 (BioRad Laboratories Inc, Hercules, CA, USA)
  - Rotor-Gene 3000/6000 (Corbette Research, Sydney, Australia)
  - ABI 7300 (Applied Biosystems, Foster City, USA)